{
    "document_id": "D-2023-2363",
    "LinkTitle": "D-2023-2363",
    "file_name": "D-2023-2363.pdf",
    "file_path": "/Users/JADEPOTTER5/Downloads/DMP-MT/processed_data/pdfs_new/org_pdfs/D-2023-2363.pdf",
    "metadata": {
        "title": "Dental Tissue Regeneration via Bioengineered Immune Modulatory Scaffolds (DREIMS)",
        "author": "N/A",
        "num_pages": 6
    },
    "content": {
        "full_text": "Dental Tissue Regeneration via Bioengineered Immune Modulatory Scaffolds (DREIMS)\nDental Tissue Regeneration via Bioengineered Immune Modulatory Scaffolds (DREIMS)\nA Data Management Plan created using DMPonline.be\nCreators: \nCreators: \nn.n. n.n., Mostafa Ezeldeen\nAffiliation: \nAffiliation: \nKU Leuven (KUL)\nFunder: \nFunder: \nBijzonder Onderzoeksfonds\nTemplate: \nTemplate: \nKU Leuven BOF-IOF\nPrincipal Investigator:\nPrincipal Investigator:\n \nMostafa Ezeldeen, n.n. n.n.\nData Manager:\nData Manager:\n \nMostafa Ezeldeen\nProject Administrator:\nProject Administrator:\n \nMostafa Ezeldeen, n.n. n.n.\nGrant number / URL: \nGrant number / URL: \nIDN/23/008/https://research.kuleuven.be/portal/en/project/3M230281\nID: \nID: \n206084\nStart date: \nStart date: \n01-10-2023\nEnd date: \nEnd date: \n30-09-2027\nProject abstract:\nProject abstract:\nOral health plays an essential role in our daily lives and wellbeing. Yet, poor oral conditions are highly prevalent, affecting almost half the world’s\npopulation, with high socio-economic burden. Treatment of conditions affecting the dental root remains highly challenging. Moreover, dental root\nreplacement with titanium implants may work for adult patients, yet in children such technique cannot be applied as an osseointegrated implant will not\nfollow dentoalveolar growth. Therefore, replacing a lost permanent tooth in children is extremely challenging. In order to offer a viable solution for\npediatric tooth loss, tissue engineering strategies utilizing combinations of scaffolds, growth factors, and stem cells, are currently in development.\nHowever, clinical success remains limited to small defects, and suffers from limited reproducibility. This project aims a novel tissue engineering\napproach for dental root tissue replacement based on multi-material scaffolds with immunomodulatory properties.\nLast modified: \nLast modified: \n31-03-2024\nCreated using DMPonline.be. Last modiﬁed 31 March 2024\n1 of 6\nDental Tissue Regeneration via Bioengineered Immune Modulatory Scaffolds (DREIMS)\nDental Tissue Regeneration via Bioengineered Immune Modulatory Scaffolds (DREIMS)\nResearch Data Summary\nResearch Data Summary\nList and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For each dataset or\nList and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For each dataset or\ndata type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know what data it is about), indicate\ndata type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know what data it is about), indicate\nwhether the data are newly generated/collected or reused, digital or physical, also indicate the type of the data (the kind of content), its\nwhether the data are newly generated/collected or reused, digital or physical, also indicate the type of the data (the kind of content), its\ntechnical format (file extension), and an estimate of the upper limit of the volume of the data.\ntechnical format (file extension), and an estimate of the upper limit of the volume of the data.\nDataset name / ID\nDescription\nNew or\nreuse\nDigital or\nPhysical\ndata\nData Type\nFile format\nData\nvolume\nPhysical\nvolume\n \n \nIndicate:\nN\nN\n(ew\ndata) or\nE\nE\n(xisting\ndata) \nIndicate: \nD\nD\n(igital)\nor\nP\nP\n(hysical)\nIndicate:\nA\nA\nudiovisual\nI\nI\nmages\nS\nS\nound\nN\nN\numerical \nT\nT\nextual\nM\nM\nodel\nSO\nSO\nftware\nOther (specify)\n \nIndicate:\n<1GB\n<100GB\n<1TB\n<5TB\n>5TB\nNA\n \nWP1: CaP Ink\ndevelopment\nDevelopment of novel calcium phosphate\ninks and in silico modelling driven design\nfor mechanically robust dental root\nshaped scaffolds\nN\nD & P\nImages from nano-CT\nscans\nModelling data from Finite\nelement analysis\nNumerical data from\nmechanical testing and\ncharacterization\nTIFF images\nmesh files\nfor\nmodelling\n(.stl)\nNumerical\ndata\nspreadsheets\nin CSV or\nXLSX\n<5TB\nat least 3\nsamples\nper-\ncondition\nWP2: Multi-\nlayered hybrid\nscaffolds\nBiofabrication of multi-layered hybrid\nscaffolds mimicking periodontal ligament\ninterface\nN\nD & P\nImages from nano-CT\nscans\nModelling data from Finite\nelement analysis\nNumerical data from\nmechanical testing and\ncharacterisation\nTIFF images\nmesh files\nfor\nmodelling\n(.stl)\nNumerical\ndata\nspreadsheets\nin CSV or\nXLSX\n<5TB\nat least 3\nsamples\nper-\ncondition\nWP3:\nAntimicrobial\nimmunomodulatory\nscaffolds\nCOAM as a novel strategy for\nantimicrobial, immunomodulatory\nscaffolds and unlocking the interplay\nbetween biomaterial immune-cell and\ndental stem cells\nN\nD & P\nNumerical data from\ncharacterisation of:\nchemokine and cytokine\nimmobilisation, in vitro\nscreening \nProteomics and\nSequencing data\nspreadsheets\nin CSV or\nXLSX\nFASTA and\nFASTQ\n<5TB\nat least 3\nsamples\nper-\ncondition\nWP4: In vivo proof\nof concept\nProof of concept for biomaterial based\nimmunomodulated \nN\nD & P\nHitsological samples and\nmicroscopy data\nMultiplexed\nimmunohistochemistry\nMicroscopy\nimages: Bio-\nformats \nMultiplexed\ndata: Bio-\nformats\n<5TB\nSections\non glass\nslides\nwill be\nstored\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nIf you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per dataset or data\nIf you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per dataset or data\ntype:\ntype:\nCreated using DMPonline.be. Last modiﬁed 31 March 2024\n2 of 6\nNA\nAre there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? If so, refer to\nAre there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? If so, refer to\nspecific datasets or data types when appropriate and provide the relevant ethical approval number.\nspecific datasets or data types when appropriate and provide the relevant ethical approval number.\nYes, animal data (Provide ECD reference number below)\nECD still to be applied for as animal experiments planned in the last year of the project (status in progress)\nWill you process personal data? If so, please refer to specific datasets or data types when appropriate and provide the KU Leuven or UZ\nWill you process personal data? If so, please refer to specific datasets or data types when appropriate and provide the KU Leuven or UZ\nLeuven privacy register number (G or S number).\nLeuven privacy register number (G or S number).\nNo\nNA\nDoes your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)?  If so,\nDoes your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)?  If so,\nplease comment per dataset or data type where appropriate. \nplease comment per dataset or data type where appropriate. \nNo\nDo existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material or Data transfer agreements,\nDo existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material or Data transfer agreements,\nResearch collaboration agreements)? If so, please explain in the comment section to what data they relate and what restrictions are in place.\nResearch collaboration agreements)? If so, please explain in the comment section to what data they relate and what restrictions are in place.\nNo\nAre there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you (re)use? If so, please\nAre there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you (re)use? If so, please\nexplain in the comment section to what data they relate and which restrictions will be asserted.\nexplain in the comment section to what data they relate and which restrictions will be asserted.\nYes\nThere might be possible patent applications, difficult to determine at the moment.\nChlorite Oxidized Oxyamylose (COAM) is a molecule patented by the Rega institute, KU Leuven as an antiviral we plan also to patent it's use\nin immunomodulated dental tissue eingineering\nDocumentation and Metadata\nDocumentation and Metadata\nClearly describe what approach will be followed to capture the accompanying information necessary to keep \nClearly describe what approach will be followed to capture the accompanying information necessary to keep \ndata understandable and usable\ndata understandable and usable\n,\n,\nfor yourself and others, now and in the future (e.g. in terms of documentation levels and types required, procedures used, Electronic Lab\nfor yourself and others, now and in the future (e.g. in terms of documentation levels and types required, procedures used, Electronic Lab\nNotebooks, README.txt files, codebook.tsv etc. where this information is recorded). \nNotebooks, README.txt files, codebook.tsv etc. where this information is recorded). \nAll data will be saved on the KU Leuven Large storage drive and organised per Workpackage and experiment date.\nWe will explore the use of Mango en Electronic lab notebooks\nWill a metadata standard be used to make it easier to \nWill a metadata standard be used to make it easier to \nfind and reuse the data\nfind and reuse the data\n?  \n?  \nCreated using DMPonline.be. Last modiﬁed 31 March 2024\n3 of 6\nIf so, please specify which metadata standard will be used. \nIf so, please specify which metadata standard will be used. \nIf not, please specify which metadata will be created to make the data easier to find and reuse. \nIf not, please specify which metadata will be created to make the data easier to find and reuse. \nNo\nAll data will be saved on the KU Leuven Large storage drive and organised per Workpackage and experiment date.\nData Storage & Back-up during the Research Project\nData Storage & Back-up during the Research Project\nWhere will the data be stored?\nWhere will the data be stored?\nLarge Volume Storage\nOneDrive (KU Leuven)\nManGO\nHow will the data be backed up?\nHow will the data be backed up?\nStandard back-up provided by KU Leuven ICTS for my storage solution\nIs there currently sufficient storage & backup capacity during the project? \nIs there currently sufficient storage & backup capacity during the project? \nIf no or insufficient storage or backup capacities are available, explain how this will be taken care of. \nIf no or insufficient storage or backup capacities are available, explain how this will be taken care of. \nYes\nHow will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? \nHow will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? \nThe data will be stored on the Large Volume Storage of the OMFS-IMPATH research group and access will be only granted to authorised\npersons.\nThe data OneDrive will be be only shared within the research consortium\nWhat are the expected costs for data storage and backup during the research project? How will these costs be covered?\nWhat are the expected costs for data storage and backup during the research project? How will these costs be covered?\nThe OMFS-IMPATH research group as the co-ordinator of the consortium will cover the costs for the data managment\nData Preservation after the end of the Research Project\nData Preservation after the end of the Research Project\nWhich data will be retained for 10 years (or longer, in agreement with other retention policies that are applicable) after the end of the project? \nWhich data will be retained for 10 years (or longer, in agreement with other retention policies that are applicable) after the end of the project? \nIn case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget issues, institutional\nIn case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget issues, institutional\npolicies...).\npolicies...).\nAll data will be preserved for 10 years according to KU Leuven RDM policy\nCreated using DMPonline.be. Last modiﬁed 31 March 2024\n4 of 6\nWhere will these data be archived (stored and curated for the long-term)? \nWhere will these data be archived (stored and curated for the long-term)? \nLarge Volume Storage (longterm for large volumes)\nWhat are the expected costs for data preservation during the expected retention period? How will these costs be covered?\nWhat are the expected costs for data preservation during the expected retention period? How will these costs be covered?\nThe OMFS-IMPATH research group as the co-ordinator of the consortium will cover the costs for the data managment\nData Sharing and Reuse\nData Sharing and Reuse\nWill the data (or part of the data) be made available for reuse after/during the project?  \nWill the data (or part of the data) be made available for reuse after/during the project?  \nPlease explain per dataset or data type which data will be made available.\nPlease explain per dataset or data type which data will be made available.\nNo (closed access)\nIf access is restricted, please specify who will be able to access the data and under what conditions. \nIf access is restricted, please specify who will be able to access the data and under what conditions. \nThe members of the project consortium\nAre there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party, legal\nAre there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party, legal\nrestrictions)? \nrestrictions)? \nPlease explain per dataset or data type where appropriate.\nPlease explain per dataset or data type where appropriate.\nYes, intellectual property rights\nNo\nWhere will the data be made available?  \nWhere will the data be made available?  \nIf already known, please provide a repository per dataset or data type.\nIf already known, please provide a repository per dataset or data type.\nOther (specify below)\nNot applicable\nWhen will the data be made available? \nWhen will the data be made available? \nUpon publication of research results\nWhich data usage licenses are you going to provide? \nWhich data usage licenses are you going to provide? \nIf none, please explain why. \nIf none, please explain why. \nCreated using DMPonline.be. Last modiﬁed 31 March 2024\n5 of 6\nCC-BY 4.0 (data)\nDo you intend to add a persistent identifier (PID) to your dataset(s), e.g. a DOI or accession number? If already available, please provide it\nDo you intend to add a persistent identifier (PID) to your dataset(s), e.g. a DOI or accession number? If already available, please provide it\nhere. \nhere. \nNo\nWhat are the expected costs for data sharing? How will these costs be covered?  \nWhat are the expected costs for data sharing? How will these costs be covered?  \nThe OMFS-IMPATH research group as the co-ordinator of the consortium will cover the costs for the data managment\nResponsibilities\nResponsibilities\nWho will manage data documentation and metadata during the research project? \nWho will manage data documentation and metadata during the research project? \nThe OMFS-IMPATH research group as a co-ordinator, also the PhD students employed in the project\nWho will manage data storage and backup during the research project? \nWho will manage data storage and backup during the research project? \nThe OMFS-IMPATH research group as a co-ordinator, also the PhD students employed in the project\nWho will manage data preservation and sharing? \nWho will manage data preservation and sharing? \nThe OMFS-IMPATH research group as a co-ordinator\nWho will update and implement this DMP? \nWho will update and implement this DMP? \nThe OMFS-IMPATH research group as a co-ordinator. Prof. Reinhilde Jacobs and Dr. Mostafa EzEldeen\nCreated using DMPonline.be. Last modiﬁed 31 March 2024\n6 of 6"
    },
    "clean_full_text": "Dental Tissue Regeneration via Bioengineered Immune Modulatory Scaffolds (DREIMS) Dental Tissue Regeneration via Bioengineered Immune Modulatory Scaffolds (DREIMS) A Data Management Plan created using DMPonline.be Creators: Creators: n.n. n.n., Mostafa Ezeldeen Affiliation: Affiliation: KU Leuven (KUL) Funder: Funder: Bijzonder Onderzoeksfonds Template: Template: KU Leuven BOF-IOF Principal Investigator: Principal Investigator: Mostafa Ezeldeen, n.n. n.n. Data Manager: Data Manager: Mostafa Ezeldeen Project Administrator: Project Administrator: Mostafa Ezeldeen, n.n. n.n. Grant number / URL: Grant number / URL: IDN/23/008/https://research.kuleuven.be/portal/en/project/3M230281 ID: ID: 206084 Start date: Start date: 01-10-2023 End date: End date: 30-09-2027 Project abstract: Project abstract: Oral health plays an essential role in our daily lives and wellbeing. Yet, poor oral conditions are highly prevalent, affecting almost half the world’s population, with high socio-economic burden. Treatment of conditions affecting the dental root remains highly challenging. Moreover, dental root replacement with titanium implants may work for adult patients, yet in children such technique cannot be applied as an osseointegrated implant will not follow dentoalveolar growth. Therefore, replacing a lost permanent tooth in children is extremely challenging. In order to offer a viable solution for pediatric tooth loss, tissue engineering strategies utilizing combinations of scaffolds, growth factors, and stem cells, are currently in development. However, clinical success remains limited to small defects, and suffers from limited reproducibility. This project aims a novel tissue engineering approach for dental root tissue replacement based on multi-material scaffolds with immunomodulatory properties. Last modified: Last modified: 31-03-2024 Created using DMPonline.be. Last modiﬁed 31 March 2024 1 of 6 Dental Tissue Regeneration via Bioengineered Immune Modulatory Scaffolds (DREIMS) Dental Tissue Regeneration via Bioengineered Immune Modulatory Scaffolds (DREIMS) Research Data Summary Research Data Summary List and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For each dataset or List and describe all datasets or research materials that you plan to generate/collect or reuse during your research project. For each dataset or data type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know what data it is about), indicate data type (observational, experimental etc.), provide a short name & description (sufficient for yourself to know what data it is about), indicate whether the data are newly generated/collected or reused, digital or physical, also indicate the type of the data (the kind of content), its whether the data are newly generated/collected or reused, digital or physical, also indicate the type of the data (the kind of content), its technical format (file extension), and an estimate of the upper limit of the volume of the data. technical format (file extension), and an estimate of the upper limit of the volume of the data. Dataset name / ID Description New or reuse Digital or Physical data Data Type File format Data volume Physical volume Indicate: N N (ew data) or E E (xisting data) Indicate: D D (igital) or P P (hysical) Indicate: A A udiovisual I I mages S S ound N N umerical T T extual M M odel SO SO ftware Other (specify) Indicate: <1GB <100GB <1TB <5TB >5TB NA WP1: CaP Ink development Development of novel calcium phosphate inks and in silico modelling driven design for mechanically robust dental root shaped scaffolds N D & P Images from nano-CT scans Modelling data from Finite element analysis Numerical data from mechanical testing and characterization TIFF images mesh files for modelling (.stl) Numerical data spreadsheets in CSV or XLSX <5TB at least 3 samples per- condition WP2: Multi- layered hybrid scaffolds Biofabrication of multi-layered hybrid scaffolds mimicking periodontal ligament interface N D & P Images from nano-CT scans Modelling data from Finite element analysis Numerical data from mechanical testing and characterisation TIFF images mesh files for modelling (.stl) Numerical data spreadsheets in CSV or XLSX <5TB at least 3 samples per- condition WP3: Antimicrobial immunomodulatory scaffolds COAM as a novel strategy for antimicrobial, immunomodulatory scaffolds and unlocking the interplay between biomaterial immune-cell and dental stem cells N D & P Numerical data from characterisation of: chemokine and cytokine immobilisation, in vitro screening Proteomics and Sequencing data spreadsheets in CSV or XLSX FASTA and FASTQ <5TB at least 3 samples per- condition WP4: In vivo proof of concept Proof of concept for biomaterial based immunomodulated N D & P Hitsological samples and microscopy data Multiplexed immunohistochemistry Microscopy images: Bio- formats Multiplexed data: Bio- formats <5TB Sections on glass slides will be stored If you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per dataset or data If you reuse existing data, please specify the source, preferably by using a persistent identifier (e.g. DOI, Handle, URL etc.) per dataset or data type: type: Created using DMPonline.be. Last modiﬁed 31 March 2024 2 of 6 NA Are there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? If so, refer to Are there any ethical issues concerning the creation and/or use of the data (e.g. experiments on humans or animals, dual use)? If so, refer to specific datasets or data types when appropriate and provide the relevant ethical approval number. specific datasets or data types when appropriate and provide the relevant ethical approval number. Yes, animal data (Provide ECD reference number below) ECD still to be applied for as animal experiments planned in the last year of the project (status in progress) Will you process personal data? If so, please refer to specific datasets or data types when appropriate and provide the KU Leuven or UZ Will you process personal data? If so, please refer to specific datasets or data types when appropriate and provide the KU Leuven or UZ Leuven privacy register number (G or S number). Leuven privacy register number (G or S number). No NA Does your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)? If so, Does your work have potential for commercial valorization (e.g. tech transfer, for example spin-offs, commercial exploitation, …)? If so, please comment per dataset or data type where appropriate. please comment per dataset or data type where appropriate. No Do existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material or Data transfer agreements, Do existing 3rd party agreements restrict exploitation or dissemination of the data you (re)use (e.g. Material or Data transfer agreements, Research collaboration agreements)? If so, please explain in the comment section to what data they relate and what restrictions are in place. Research collaboration agreements)? If so, please explain in the comment section to what data they relate and what restrictions are in place. No Are there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you (re)use? If so, please Are there any other legal issues, such as intellectual property rights and ownership, to be managed related to the data you (re)use? If so, please explain in the comment section to what data they relate and which restrictions will be asserted. explain in the comment section to what data they relate and which restrictions will be asserted. Yes There might be possible patent applications, difficult to determine at the moment. Chlorite Oxidized Oxyamylose (COAM) is a molecule patented by the Rega institute, KU Leuven as an antiviral we plan also to patent it's use in immunomodulated dental tissue eingineering Documentation and Metadata Documentation and Metadata Clearly describe what approach will be followed to capture the accompanying information necessary to keep Clearly describe what approach will be followed to capture the accompanying information necessary to keep data understandable and usable data understandable and usable , , for yourself and others, now and in the future (e.g. in terms of documentation levels and types required, procedures used, Electronic Lab for yourself and others, now and in the future (e.g. in terms of documentation levels and types required, procedures used, Electronic Lab Notebooks, README.txt files, codebook.tsv etc. where this information is recorded). Notebooks, README.txt files, codebook.tsv etc. where this information is recorded). All data will be saved on the KU Leuven Large storage drive and organised per Workpackage and experiment date. We will explore the use of Mango en Electronic lab notebooks Will a metadata standard be used to make it easier to Will a metadata standard be used to make it easier to find and reuse the data find and reuse the data ? ? Created using DMPonline.be. Last modiﬁed 31 March 2024 3 of 6 If so, please specify which metadata standard will be used. If so, please specify which metadata standard will be used. If not, please specify which metadata will be created to make the data easier to find and reuse. If not, please specify which metadata will be created to make the data easier to find and reuse. No All data will be saved on the KU Leuven Large storage drive and organised per Workpackage and experiment date. Data Storage & Back-up during the Research Project Data Storage & Back-up during the Research Project Where will the data be stored? Where will the data be stored? Large Volume Storage OneDrive (KU Leuven) ManGO How will the data be backed up? How will the data be backed up? Standard back-up provided by KU Leuven ICTS for my storage solution Is there currently sufficient storage & backup capacity during the project? Is there currently sufficient storage & backup capacity during the project? If no or insufficient storage or backup capacities are available, explain how this will be taken care of. If no or insufficient storage or backup capacities are available, explain how this will be taken care of. Yes How will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? How will you ensure that the data are securely stored and not accessed or modified by unauthorized persons? The data will be stored on the Large Volume Storage of the OMFS-IMPATH research group and access will be only granted to authorised persons. The data OneDrive will be be only shared within the research consortium What are the expected costs for data storage and backup during the research project? How will these costs be covered? What are the expected costs for data storage and backup during the research project? How will these costs be covered? The OMFS-IMPATH research group as the co-ordinator of the consortium will cover the costs for the data managment Data Preservation after the end of the Research Project Data Preservation after the end of the Research Project Which data will be retained for 10 years (or longer, in agreement with other retention policies that are applicable) after the end of the project? Which data will be retained for 10 years (or longer, in agreement with other retention policies that are applicable) after the end of the project? In case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget issues, institutional In case some data cannot be preserved, clearly state the reasons for this (e.g. legal or contractual restrictions, storage/budget issues, institutional policies...). policies...). All data will be preserved for 10 years according to KU Leuven RDM policy Created using DMPonline.be. Last modiﬁed 31 March 2024 4 of 6 Where will these data be archived (stored and curated for the long-term)? Where will these data be archived (stored and curated for the long-term)? Large Volume Storage (longterm for large volumes) What are the expected costs for data preservation during the expected retention period? How will these costs be covered? What are the expected costs for data preservation during the expected retention period? How will these costs be covered? The OMFS-IMPATH research group as the co-ordinator of the consortium will cover the costs for the data managment Data Sharing and Reuse Data Sharing and Reuse Will the data (or part of the data) be made available for reuse after/during the project? Will the data (or part of the data) be made available for reuse after/during the project? Please explain per dataset or data type which data will be made available. Please explain per dataset or data type which data will be made available. No (closed access) If access is restricted, please specify who will be able to access the data and under what conditions. If access is restricted, please specify who will be able to access the data and under what conditions. The members of the project consortium Are there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party, legal Are there any factors that restrict or prevent the sharing of (some of) the data (e.g. as defined in an agreement with a 3rd party, legal restrictions)? restrictions)? Please explain per dataset or data type where appropriate. Please explain per dataset or data type where appropriate. Yes, intellectual property rights No Where will the data be made available? Where will the data be made available? If already known, please provide a repository per dataset or data type. If already known, please provide a repository per dataset or data type. Other (specify below) Not applicable When will the data be made available? When will the data be made available? Upon publication of research results Which data usage licenses are you going to provide? Which data usage licenses are you going to provide? If none, please explain why. If none, please explain why. Created using DMPonline.be. Last modiﬁed 31 March 2024 5 of 6 CC-BY 4.0 (data) Do you intend to add a persistent identifier (PID) to your dataset(s), e.g. a DOI or accession number? If already available, please provide it Do you intend to add a persistent identifier (PID) to your dataset(s), e.g. a DOI or accession number? If already available, please provide it here. here. No What are the expected costs for data sharing? How will these costs be covered? What are the expected costs for data sharing? How will these costs be covered? The OMFS-IMPATH research group as the co-ordinator of the consortium will cover the costs for the data managment Responsibilities Responsibilities Who will manage data documentation and metadata during the research project? Who will manage data documentation and metadata during the research project? The OMFS-IMPATH research group as a co-ordinator, also the PhD students employed in the project Who will manage data storage and backup during the research project? Who will manage data storage and backup during the research project? The OMFS-IMPATH research group as a co-ordinator, also the PhD students employed in the project Who will manage data preservation and sharing? Who will manage data preservation and sharing? The OMFS-IMPATH research group as a co-ordinator Who will update and implement this DMP? Who will update and implement this DMP? The OMFS-IMPATH research group as a co-ordinator. Prof. Reinhilde Jacobs and Dr. Mostafa EzEldeen Created using DMPonline.be. Last modiﬁed 31 March 2024 6 of 6"
}